Open AccessEfficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
Author(s) -
Jian Sun,
Chen-Fan Kong,
Xiang-Ke Qu,
Chao Deng,
Yanni Lou,
Liqun Jia
Publication year - 2020
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_384_19
Subject(s) - jadad scale , irritable bowel syndrome , medicine , randomized controlled trial , adverse effect , flatulence , placebo , meta analysis , medline , bloating , abdominal pain , quality of life (healthcare) , cinahl , physical therapy , alternative medicine , cochrane library , psychiatry , psychological intervention , pathology , political science , law , nursing
Irritable Bowel Syndrome (IBS) is a common chronic functional bowel disorder and the evidence shows most drug therapies in the treatment of IBS are weak. Recently, some studies showed probiotics may have a positive effect in IBS and they are widely used to improve the symptom of IBS, which indicate probiotics may play an important role in the treatment of IBS. However, the exact effectiveness and safety of probiotics are largely unknown. This systematic review focuses on identifying the efficacy and safety of probiotics in the treatment of IBS.